跳至主要内容
临床试验/NCT01733342
NCT01733342已完成4 期

Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 176 人开始时间: 2012年11月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
176
试验地点
1
主要终点
function of chemoport

研究概览

简要总结

To compare the performance of domestic chemoport and imported chemoport

详细描述

chemoport implantation was done by two investigator Chemoport type was randomly rendered. Domestic chemoport(Human port) and imported chemoport (Celsite) were used. chemoport function will be followed up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients who will receive chemotherapy via implantable port
  • •age >20 years
  • •expected life time > 6 months
  • •lab test (platelet>50K, PT INR <2.0)

排除标准

  • •performance status >2
  • •brain metastasis
  • •expected life time less than 6 months
  • •age less than 20 years
  • •active infection
  • •severe heart dysfunction
  • •recent myocardial infarct

研究组 & 干预措施

Celsite

Active Comparator

patients received celsite chemoport implantation under local anesthesia

干预措施: Celsite chemoport implantation (Device)

Celsite

Active Comparator

patients received celsite chemoport implantation under local anesthesia

干预措施: local anesthesia (Procedure)

Humanport

Experimental

patients received Humanport chemoport implantation under local anesthesia

干预措施: local anesthesia (Procedure)

Humanport

Experimental

patients received Humanport chemoport implantation under local anesthesia

干预措施: Humanport chemoport implantation (Device)

结局指标

主要结局

function of chemoport

时间窗: 6 months

Whether or not chemoport function is intact will be assessed. Chemoport function will be rendered as intact when chemotherapeutic agent is well infused through the chemoport. Chemoport function will be rendered as not intact when chemotherapeutic agent could be infused through the chemoport.

次要结局

  • infection(6 months)
  • Skin dehiscence(6 months)
  • deep vein thrombosis(6 months)
  • Fibrin sheath(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyo-Cheol Kim

Clinical Assistant Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验